Adtalem Weighs Enrollment Momentum And Buybacks Against Recent Share Weakness

• Adtalem Global Education (NYSE:ATGE) has reported its tenth consecutive quarter of student enrollment growth.
• The company has completed a $150 million share repurchase program and authorized a new $750 million buyback.
• Adtalem is expanding partnerships with health systems and adding AI elements into its academic programs.

Adtalem Global Education, trading at $103.55, has seen a mixed share price pattern, with a 14.6% decline over the past week and a 3.3% decline over the past year, alongside very large gains over the past 3 and 5 years. For investors tracking education and healthcare training, this blend of long term strength and recent weakness may prompt a closer look at how current operations line up with the stock’s recent moves.

The combination of ongoing enrollment momentum, sizeable new buyback capacity and deeper integration of AI and health system partnerships reflects a company that is actively reshaping its educational offering. Readers may want to watch how these moves relate to student outcomes, program mix and capital allocation over time, as those factors often influence how the market values a business like NYSE:ATGE.

Stay updated on the most important news stories for Adtalem Global Education by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Adtalem Global Education.

Why Adtalem Global Education could be great value

Investor Checklist

Quick Assessment

• ✅ Price vs Analyst Target: At US$103.55 versus a US$161.50 analyst target, the price is about 36% below consensus.
• ✅ Simply Wall St Valuation: The shares are described as trading 54.3% below estimated fair value.
• ✅ Recent Momentum: The 30 day return of 0.08% is essentially flat, which may give you time to assess the latest news.

Check out Simply Wall St's in depth valuation analysis for Adtalem Global Education.

Key Considerations

• 📊 Ten straight quarters of enrollment growth, larger buybacks and AI infused programs all speak to how management is positioning the business today.
• 📊 Watch the US$750m repurchase execution, enrollment trends and any updates on health system partnerships as potential drivers of sentiment.
• ⚠️ Education providers can face regulatory, funding or reputational shocks, so it is worth checking for any company specific risk disclosures even when none are flagged here.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Adtalem Global Education analysis.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com